Obesity Surgery

, Volume 29, Issue 2, pp 609–616 | Cite as

Laparoscopic Roux-En-Y Gastric Bypass Versus Sleeve Gastrectomy on Pelvic Floor Disorders in Morbidly Obese Women: a Prospective Monocentric Pilot Study

  • Clémentine Mazoyer
  • Patrick Treacy
  • Laurent Turchi
  • Paul Antoine Lehur
  • Emmanuel Benizri
  • Antonio IannelliEmail author
Original Contributions



Obesity is a well-known risk factor for female pelvic floor disorders (PFD). This study assessed the effects of bariatric surgery (BS) on pelvic organ prolapse symptoms (POPs) and urinary (UI) and anal incontinence (AI) in morbidly obese women undergoing either sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).


Morbidly obese women undergoing BS from June 2016 to May 2017 were prospectively included. POPs, UI, and AI were compared at baseline and at 1 year after surgery using validated questionnaires.


Seventy-two consecutive women were enrolled, 54 (75%) (30 (56%) RYBP and 24 (44%) SG) completed the study at 1 year and were considered for the final analysis. The mean age and mean preoperative BMI were 43 ± 11.8 years (range, 20–65) and 41 ± 5.4 kg/m2 (range, 35–56), respectively. At baseline, 30 (56%), 32 (59%), and 27 (50%) patients, respectively, had AI (flatus only 72%), UI, and POPs. The mean TBWL% at 1 year was 33%. In the whole study population, weight loss was associated with a significant improvement in UI (p < 0.001) but there was no significant difference in terms of AI and POPs. In the subgroups analysis, AI increased significantly 1 year after the RYGB (p = 0.02) due to an increase in flatus incontinence (p = 0.04). No significant difference in AI was found 1 year after the SG.


BS is associated with a significant improvement in UI but not in POPs. RYBP seems to increase AI, mainly flatus incontinence, compared to SG.


Bariatric surgery Obesity Pelvic floor disorders Anal incontinence Urinary incontinence Pelvic organ prolapse Roux-en-Y gastric bypass Sleeve gastrectomy 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Patients were informed through a written notice on the purpose of the study.

Ethical Approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments.


  1. 1.
    Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–6.CrossRefGoogle Scholar
  2. 2.
    Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123:141–8.CrossRefGoogle Scholar
  3. 3.
    Wasserberg N, Haney M, Petrone P, et al. Morbid obesity adversely impacts pelvic floor function in females seeking attention for weight loss surgery. Dis Colon Rectum. 2007;50:2096–103.CrossRefGoogle Scholar
  4. 4.
    Chen CCG, Gatmaitan P, Koepp S, et al. Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis. 2009;5:411–5.CrossRefGoogle Scholar
  5. 5.
    Neto IJFC, Pinto RA, Jorge JMN, et al. Are obese patients at an increased risk of pelvic floor dysfunction compared to non-obese patients? Obes Surg. 2017;27:1822–7.CrossRefGoogle Scholar
  6. 6.
    Cuicchi D, Lombardi R, Cariani S, et al. Clinical and instrumental evaluation of pelvic floor disorders before and after bariatric surgery in obese women. Surg Obes Relat Dis. 2013;9:69–75.CrossRefGoogle Scholar
  7. 7.
    Noblett KL, Jensen JK, Ostergard DR. The relationship of body mass index to intra-abdominal pressure as measured by multichannel cystometry. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8:323–6.CrossRefGoogle Scholar
  8. 8.
    Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369:1027–38.CrossRefGoogle Scholar
  9. 9.
    Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefGoogle Scholar
  10. 10.
    Major P, Matłok M, Pędziwiatr M, et al. Quality of life after bariatric surgery. Obes Surg. 2015;25:1703–10.CrossRefGoogle Scholar
  11. 11.
    Wasserberg N, Petrone P, Haney M, et al. Effect of surgically induced weight loss on pelvic floor disorders in morbidly obese women. Ann Surg. 2009;249:72–6.CrossRefGoogle Scholar
  12. 12.
    Leshem A, Shimonov M, Amir H, et al. Effects of bariatric surgery on female pelvic floor disorders. Urology. 2017;105:42–7.CrossRefGoogle Scholar
  13. 13.
    Pomian A, Majkusiak W, Lisik W, Tomasik P, Horosz E, Zwierzchowska A, et al. Is bariatric surgery a prophylaxis for pelvic floor disorders? Obes Surg 2017;Google Scholar
  14. 14.
    Lian W, Zheng Y, Huang H, et al. Effects of bariatric surgery on pelvic floor disorders in obese women: a meta-analysis. Arch Gynecol Obstet. 2017;296:181–9.CrossRefGoogle Scholar
  15. 15.
    Knepfler T, Valero E, Triki E, et al. Bariatric surgery improves female pelvic floor disorders. J Visc Surg. 2016;153:95–9.CrossRefGoogle Scholar
  16. 16.
    Scozzari G, Rebecchi F, Giaccone C, et al. Bariatric surgery improves urinary incontinence but not anorectal function in obese women. Obes Surg. 2013;23:931–8.CrossRefGoogle Scholar
  17. 17.
    Wasserberg N, Haney M, Petrone P, et al. Fecal incontinence among morbid obese women seeking for weight loss surgery: an underappreciated association with adverse impact on quality of life. Int J Color Dis. 2008;23:493–7.CrossRefGoogle Scholar
  18. 18.
    Potoczna N, Harfmann S, Steffen R, et al. Bowel habits after bariatric surgery. Obes Surg. 2008;18:1287–96.CrossRefGoogle Scholar
  19. 19.
    Wasserberg N, Hamoui N, Petrone P, et al. Bowel habits after gastric bypass versus the duodenal switch operation. Obes Surg. 2008;18:1563–6.CrossRefGoogle Scholar
  20. 20.
    Foster A, Laws HL, Gonzalez QH, et al. Gastrointestinal symptomatic outcome after laparoscopic Roux-en-Y gastric bypass. J Gastrointest Surg. 2003;7:750–3.CrossRefGoogle Scholar
  21. 21.
    Poylin V, Serrot FJ, Madoff RD, et al. Obesity and bariatric surgery: a systematic review of associations with defecatory dysfunction. Colorectal. 2011;13:e92–103.CrossRefGoogle Scholar
  22. 22.
    Borbély YM, Osterwalder A, Kröll D, et al. Diarrhea after bariatric procedures: diagnosis and therapy. World J Gastroenterol. 2017;23:4689–700.CrossRefGoogle Scholar
  23. 23.
    Elias K, Bekhali Z, Hedberg J, et al. Changes in bowel habits and patient-scored symptoms after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2018;14:144–9.CrossRefGoogle Scholar
  24. 24.
    NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991;115:956–61.Google Scholar
  25. 25.
    Benois M, Sebastianelli L, Morisot A, et al. Revisional but not conversional gastric bypass surgery increases the risk of leaks: review of 176 redo out of 932 consecutive cases. Obes Surg. 2018;28:2903–11.CrossRefGoogle Scholar
  26. 26.
    Haab F, Richard F, Amarenco G, et al. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the urinary symptom profile (USP) questionnaire. Urology. 2008;71:646–56.CrossRefGoogle Scholar
  27. 27.
    Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193:103–13.CrossRefGoogle Scholar
  28. 28.
    de Tayrac R, Deval B, Fernandez H, et al. Development of a linguistically validated French version of two short-form, condition-specific quality of life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). J Gynecol Obstet Biol Reprod. 2007;36:738–48.CrossRefGoogle Scholar
  29. 29.
    Altman D, Falconer C, Rossner S, et al. The risk of anal incontinence in obese women. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:1283–9.CrossRefGoogle Scholar
  30. 30.
    Shao Y, Ding R, Xu B, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg. 2017;27:295–302.CrossRefGoogle Scholar
  31. 31.
    Murphy R, Tsai P, Jüllig M, et al. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg. 2017;27:917–25.CrossRefGoogle Scholar
  32. 32.
    Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg. 2013;148:563–9.CrossRefGoogle Scholar
  33. 33.
    Ishida RK, Faintuch J, Paula AMR, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17:752–8.CrossRefGoogle Scholar
  34. 34.
    Ishida RK, Faintuch J, Ribeiro AS, et al. Asymptomatic gastric bacterial overgrowth after bariatric surgery: are long-term metabolic consequences possible? Obes Surg. 2014;24:1856–61.CrossRefGoogle Scholar
  35. 35.
    Leshem A, Groutz A, Amir H, Gordon D, Shimonov M. Surgically induced weight loss results in a rapid and consistent improvement of female pelvic floor symptoms. Scand J Urol 2018;1–6.Google Scholar
  36. 36.
    Romero-Talamás H, Unger CA, Aminian A, et al. Comprehensive evaluation of the effect of bariatric surgery on pelvic floor disorders. Surg Obes Relat Dis. 2016;12:138–43.CrossRefGoogle Scholar
  37. 37.
    O’Boyle CJ, O’Sullivan OE, Shabana H, et al. The effect of bariatric surgery on urinary incontinence in women. Obes Surg. 2016;26:1471–8.CrossRefGoogle Scholar
  38. 38.
    Gabriel I, Tavakkoli A, Minassian VA. Pelvic organ prolapse and urinary incontinence in women after bariatric surgery: 5-year follow-up. Female Pelvic Med Reconstr Surg. 2018;24:120–5.CrossRefGoogle Scholar
  39. 39.
    Osborn DJ, Strain M, Gomelsky A, et al. Obesity and female stress urinary incontinence. Urology. 2013;82:759–63.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Digestive Unit, Archet 2 HospitalUniversity Hospital of NiceNiceFrance
  2. 2.Université Côte d’AzurNiceFrance
  3. 3.Inserm U1091 - CNRS UMR7277 - Institut de Biologie ValroseUniversité Nice Sophia AntipolisNiceFrance
  4. 4.Department of Digestive and Endocrine SurgeryUniversity Hospital of NantesNantesFrance
  5. 5.Inserm, U1065, Team 8 “Hepatic complications of obesity”NiceFrance
  6. 6.Service de Chirurgie Digestive et Centre de Transplantation HépatiqueHôpital Archet 2Nice Cedex3France

Personalised recommendations